Fiche publication
Date publication
octobre 2018
Journal
Multiple sclerosis and related disorders
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Defer G, de Seze J, Bouee S, Courouve L, Longin J, Payet M, Deleglise ASJ,
Lien Pubmed
Résumé
Despite a recent interest in Real World Data, such studies are scarce in multiple sclerosis (MS) disease. The objective was to describe the patients, disease progression and use of DMDs in France and compare clinical effectiveness of first-line injectable DMDs.
Mots clés
Adolescent, Adult, Age Distribution, Cohort Studies, Disability Evaluation, Disease Management, Disease Progression, Female, France, epidemiology, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Multiple Sclerosis, epidemiology, Patient Compliance, Treatment Outcome, Young Adult
Référence
Mult Scler Relat Disord. 2018 Oct;25:276-281
